Aubagio Oral Tablet 14Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

AUBAGIO: Oral tablet (14mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TERIFLUNOMIDE (TER i FLOO noe mide) treats multiple sclerosis. It can decrease the number of flare-ups. This medicine is not a cure.

In-Depth Information

AUBAGIO 14mg Tablet

NDC: 584680210
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Sclerosis

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
AUBAGIO 14mg Tablet

Reported Side Effects for AUBAGIO 14mg Tablet

Hives Incidence:
0.8-1.1%*
Severity: MILD
Onset: RAPID
Infection Incidence:
1.2-53.0%*
Severity: MILD
Onset: DELAYED
Nerve Pain Incidence:
1.4-1.9%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
2.8-3.5%*
Severity: MILD
Onset: RAPID
High Blood Pressure Incidence:
3.1-4.3%*
Severity: MODERATE
Onset: EARLY
Low White Blood Cells Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
4.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
5.8-22.7%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
6.0-8.0%*
Severity: MILD
Onset: DELAYED
Bladder Infection Incidence:
7.3-23.5%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
8.0-36.4%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
8.0-9.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
8.0-11.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
9.0-34.6%*
Severity: MILD
Onset: EARLY
Flu Incidence:
9.2-34.8%*
Severity: MILD
Onset: DELAYED
Low Lymphocytes Incidence:
10.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
10.0-48.5%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
10.0-13.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
13.0-14.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
16.0-18.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
16.7-22.2%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
21.0-53.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
21.2-22.2%*
Severity: MILD
Onset: EARLY
Overactive Reflexes Incidence:
21.2-23.5%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
48.1-50.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More